Abstract:Lynch syndrome (LS) is an autosomal dominant condition caused by germline mutations in DNA mismatch repair pathway genes that predispose individuals to develop colorectal cancer (CRC) and other malignancies. Not all LS patients develop CRC, and age at diagnosis varies significantly, even among individuals with identical mutations. Although several prospective genetic modifiers have been reported, the contribution of environmental exposures to colorectal carcinogenesis and age of onset is unknown. The gut microbiota composition, influenced by environmental factors, may have a role in CRC development. Dysbiosis, or abnormalities in host-bacteria interactions, can lead to inflammatory bowel disorders and CRC. Certain strains of bacteria, like Escherichia coli and Enterococcus sp., harbor pro-inflammatory/genotoxic genes that promote sustained inflammation in the host- pks, tcpc, gelE, cnf-1, usp, and murB. The association between inflammation and carcinogenesis is well established, yet the contribution of bacteria-induced inflammation and genotoxicity to CRN is not fully understood. This study aims to investigate if changes in the prevalence of the genotoxic/pro-inflammatory bacterial genes are associated with CRN in LS patients. Stool samples were collected from 32 LS subjects and 94 age/gender-matched control subjects without a history of CRC. Qualitative data regarding the six genes in these samples were assessed using RT-PCR with SYBR green. Among LS subjects, 68.8% had two or more of the six genes in their stool samples, whereas controls only had 27.7%. Furthermore, LS subjects had 4.06 times the odds of having ≥2 gut bacterial toxin genes in their stool (95% CI: 1.48-11.12) when compared to controls after adjusting by age. The most prevalent gene in LS patients was murB, detected in 62.5% of the individuals. The presence of gelE and murB genes was significantly higher among LS patients (p-value <0.001 and 0.02, respectively). Interestingly, the usp gene was absent in any LS patients. Additionally, LS subjects had 4.52 times the odds of having the gel-E gene (95% CI: 1.69-12.14) compared to controls after age adjustment. Given the documented evidence about the impact of CRC on the composition of gut microbiota, we performed analysis to assess the prevalence of these genes in LS subjects without a history of CRC, as well as in control subjects. After adjusting by age, LS subjects had higher odds of having ≥2 gut bacterial toxin genes in their stool (OR= 2.94, 95%: CI 0.52-16.50) than controls. This study shows that LS patients have a higher prevalence of the genotoxic/pro-inflammatory bacterial genes. However, further studies are necessary to validate these associations and provide a more comprehensive understanding of the role of gut bacterial genes in colorectal neoplasia among LS patients. Citation Format: Ingrid Montes-Rodriguez, Diego Rodriguez-Santiago, Nicole Marquez-Andino, Gabriela Montalvo-Noguera, Sophia Colon-Serrano, Luis R. Llanos, Olga Diaz-Miranda, Hilmaris Centeno-Girona, Maria Gonzalez-Pons, Marcia Cruz-Correa. Association of gut bacterial toxins with colorectal neoplasia in Lynch syndrome patients in Puerto Rico [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 752.

Fusobacterium species are distinctly associated with patients with Lynch syndrome colorectal cancer

Gut Microbiota Analysis in Postoperative Lynch Syndrome Patients

Dysbiosis Signature of Fecal Microbiota in Colorectal Cancer Patients

Fusobacteria alterations are associated with colorectal cancer liver metastasis and a poor prognosis

Loss of symbiotic and increase of virulent bacteria through microbial networks in Lynch syndrome colon carcinogenesis

Structure of the Mucosal and Stool Microbiome in Lynch Syndrome

Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer

Abstract 752: Association of gut bacterial toxins with colorectal neoplasia in Lynch syndrome patients in Puerto Rico

Human Intestinal Lumen and Mucosa-Associated Microbiota in Patients with Colorectal Cancer

Genetic spectrum of familial colorectal cancer based on Chinese clinical criteria of Lynch syndrome: study based on a multicenter population

Enrichment of oral-derived bacteria in inflamed colorectal tumors and distinct associations of Fusobacterium in the mesenchymal subtype

Fecal and Tissue Microbiota Are Associated with Tumor T-Cell Infiltration and Mesenteric Lymph Node Involvement in Colorectal Cancer

Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis

Data from <i>Fusobacterium Nucleatum</i> Promotes the Development of Colorectal Cancer by Activating a Cytochrome P450/Epoxyoctadecenoic Acid Axis via TLR4/Keap1/NRF2 Signaling

Disease-associated Gut Microbiome and Critical Metabolomic Alterations in Patients with Colorectal Cancer

Mucosal Microbiota from Colorectal Cancer, Adenoma and Normal Epithelium Reveals the Imprint of Fusobacterium nucleatum in Cancerogenesis

Novel insights into tumorigenesis revealed by molecular analysis of Lynch syndrome cases with multiple colorectal tumors

Gut Microbiota Signatures in Tumor, Para-Cancerous, Normal Mucosa, and Feces in Colorectal Cancer Patients

Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status

A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche

Southern Chinese Populations Harbour Non-Nucleatum Fusobacteria Possessing Homologues of the Colorectal Cancer-Associated FadA Virulence Factor.